CIK 0000748592 · Non-accelerated filer<br>Smaller reporting company
Ernexa Therapeutics Inc.
Sign in to watch- Ticker
- ERNA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 311103425
- Phone
- (617) 798-6700
- Business address
- 1035 CAMBRIDGE STREET, SUITE 18A, CAMBRIDGE, MA, 02141
- Former names
- Eterna Therapeutics Inc., Brooklyn ImmunoTherapeutics, Inc., NTN BUZZTIME INC, NTN COMMUNICATIONS INC
Securities
- ERNA Common Stock Nasdaq
- ERNAW Warrants Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 89 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-12-14 | Cherington Charles 10% owner | Purchase · Warrants (right to buy) | +2,307,692 | 2,307,692 | ||
| 2023-12-14 | Cherington Charles 10% owner | Other disposition · Warrants (right to buy) | −523,512 | 0 | ||
| 2023-12-14 | Cherington Charles 10% owner | Purchase · Warrants (right to buy) | +523,512 | 523,512 | ||
| 2023-12-14 | Freebird Partners LP 10% owner | Returned to the company · Common Stock Purchase Warrant | +424,928 | 524,474 | ||
| 2023-12-14 | Freebird Partners LP 10% owner | Grant or award · Common Stock Purchase Warrant | +424,928 | 949,402 | ||
| 2023-12-14 | Freebird Partners LP 10% owner | Returned to the company · Common Stock Purchase Warrant | +524,474 | 424,928 | ||
| 2023-12-14 | Freebird Partners LP 10% owner | Grant or award · Common Stock Purchase Warrant | +524,474 | 949,402 | ||
| 2023-07-14 | Freebird Partners LP 10% owner | Purchase · Convertible Note Shares | +262,237 | $2.86 | $750K | 262,237 |
| 2023-07-14 | Freebird Partners LP 10% owner | Purchase · Common Stock Purchase Warrant | +524,474 | 949,402 | ||
| 2023-07-13 | Cherington Charles 10% owner | Purchase · 6.0% Senior Convertible Promissory Notes due 2028 | +0 | $3,300,000.00 | $0 | |
| 2023-07-13 | Cherington Charles 10% owner | Purchase · Warrants (right to buy) | +2,307,692 | $0.13 | $288K | 2,307,692 |
| 2023-07-13 | BINDER BRANT Director | Purchase · 6.0% Senior Convertible Promissory Notes due 2028 | +0 | $120,000.00 | $0 | |
| 2023-07-13 | BINDER BRANT Director | Purchase · Warrants (right to buy) | +83,916 | $0.13 | $10K | 83,916 |
| 2023-07-13 | WAGNER RICHARD W Director | Purchase · 6.0% Senior Convertible Promissory Notes due 2028 | +0 | $120,000.00 | $0 | |
| 2023-07-13 | WAGNER RICHARD W Director | Purchase · Warrants (right to buy) | +83,916 | $0.13 | $10K | 83,916 |
| 2023-06-21 | Gurrola Sandra M Vice President of Finance | Option exercise | +438 | 1,107 | ||
| 2023-06-21 | Gurrola Sandra M Vice President of Finance | Shares withheld for taxes | −179 | $2.48 | $444 | 928 |
| 2023-06-21 | Gurrola Sandra M Vice President of Finance | Option exercise · Restricted Stock Units | −438 | 874 | ||
| 2023-01-12 | Angel Matthew President and CEO | Grant or award · Stock Option (right to buy) | +132,003 | 132,003 | ||
| 2022-12-02 | Cherington Charles Director | Purchase | +261,756 | $3.28 | $859K | 556,465 |
Page 4 of 33 · 657 trades